全链条促进化妆品产业高质量发展

Core Viewpoint - The National Medical Products Administration (NMPA) is focusing on enhancing the regulatory framework for cosmetics in 2026, emphasizing the importance of safety and high-quality development in the industry [1] Group 1: Regulatory Focus - The NMPA held a meeting on December 29 to summarize the achievements of regulatory work in 2025 and analyze the current situation for 2026 [1] - The year 2026 marks the beginning of the "14th Five-Year Plan," and the NMPA aims to implement the spirit of the 20th National Congress of the Communist Party of China [1] Group 2: Strategic Goals - The NMPA plans to deepen the reform of the entire regulatory process and strengthen safety measures across the cosmetics industry [1] - The meeting highlighted the need for a comprehensive approach to promote high-quality development throughout the entire supply chain of the cosmetics industry [1] Group 3: Stakeholder Engagement - Representatives from various NMPA departments, local drug regulatory agencies, and other relevant organizations participated in the meeting [1] - During the visit to Shijiazhuang, NMPA officials conducted on-site research at local drug and medical device inspection and research institutions [1]